Dane Sobek, MD
Cardiovascular Disease · Bozeman, MTNPI 1043257306
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $6,224 of the $8,197 with a category attached, or 75.9%. 7 manufacturers reported payments, led by Abbott at 49.7% of the total. Reporting peaked in 2019 at $2,959 and has fallen 87.2% since, to $379 in 2025.
Across 73 payments — averaging $112.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$4K
- Medtronic$4K
- Abiomed$278
- W. L. Gore & Associates, Inc.$151
- Argon Medical Devices, Inc.$20
- Biosense Webster, Inc.$18
- plus $17 from 1 others
What the payments were for
- Travel & lodging$6,22476%
- Food & beverage$1,97424%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 26 | $4,073 |
| Medtronic(2 entities) | 39 | $3,640 |
| Abiomed | 3 | $278 |
| W. L. Gore & Associates, Inc. | 2 | $151 |
| Argon Medical Devices, Inc. | 1 | $20 |
| Biosense Webster, Inc. | 1 | $18 |
| Impulse Dynamics (USA) Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AVEIR$1,982
- Xience V coronary stent system$1,666
- Micra$1,563
- SelectSecure$280
- GORE CARDIOFORM ASD Occluder$107
How this compares
$8,197 in reported general payments places this provider in the 85th percentile of 49 cardiovascular disease providers in Montana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 40 | $374 |
| Metoprolol Succinate | 19 | $125 |
| Cephalexin | 15 | $23 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Bozeman
- Vincenzo PolsinelliBozeman$1K
- Ronald ChinBozeman$1K
- Sara KlingerBozeman$284
- Sean BellBozeman$181
- Preston SchneiderBozeman$96
- Blair ErbBozeman$81
- Alexander TaylorBozeman$67
- Benjamin PlankBillings$46K
- Alrich GrayGreat Falls$34K
- Robert MitchellKalispell$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.